Quidel Corp. (QDEL) PT Raised to $27 at Barclays; Reiterates Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to Quidel Corp. (QDEL) PT Raised to $27 at Barclays; Reiterates Overweight

Quidel Reports First Quarter 2017 Financial Results

April 24, 2017 4:10 PM EDT

SAN DIEGO, CA -- (Marketwired) -- 04/24/17 -- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter ended March 31, 2017.

First Quarter 2017 Highlights:

Total revenue was $73.7 million as compared to $50.3 million in the first quarter of 2016.Total influenza revenue increased 112% from the first quarter of 2016 to $40.8 million. Total Molecular revenues increased 48%... More